Skip to main content
. 2021 Jul 15;22(14):7568. doi: 10.3390/ijms22147568

Figure 1.

Figure 1

Structures of the compounds: (a)—cis-diamminedichloroplatinum (II) (cisplatin, CDDP) 1; (b)—cis-dichlorobis (3-imino-2-methoxyflavanone)ruthenium (II) (134) 2; (c)—cis-dichlorobis(3-imino-2-ethoxyflavanone)ruthenium(II) (138) 3; (d)—trans-dichlorobis(3-aminoflavone)platinum(II) (TCAP) 4.